Safeguard Scientifics (SFE) Cash Flow Statement

Click line-items for a historical chart and %

Net cash used in operating activities	-14.11M
Investment in restricted cash equivalents for interest on convertible senior debentures
Proceeds from sales of and distributions from companies and funds	73.85M
Advances to partner companies	-17.74M
Repayment of advances to partner companies	1.74M
Acquisitions of ownership interests in partner companies and funds	-34.84M
Increase in marketable securities	-18.73M
Decrease in marketable securities	35.39M
Capital expenditures	-73K
Proceeds from sale of discontinued operations, net
Other, net
Net cash provided by (used in) investing activities	39.59M
Costs on exchange of convertible senior debentures
Repurchase of convertible senior debentures
Issuance of Company common stock, net	5K
Net cash used in financing activities	-5.82M
Net Increase (Decrease) in Cash and Cash Equivalents	19.66M
Cash and Cash Equivalents at beginning of period	32.84M
Cash and Cash Equivalents at end of period	52.5M

Entities mentioned with SFE

View All Entities